Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Agouron's IND for anticancer agent approved

June 20, 1997

Sugen receives notices of allowance covering SU-101 for solid tumor treatment

June 19, 1997

NeoPharm begins phase I/II trial for liposome-encapsulated doxorubicin

June 18, 1997

Results from phase II trial with thalidomide for prostate cancer reported

June 18, 1997

Suntory prepares compounds for thrombocytopenia

June 17, 1997

Merck & Co. prepares improved inhibitors of protein farnesyltransferase

June 17, 1997

U.S. notice of patent allowance for troponin I

June 16, 1997

Banyu to shift development from NB-506 to new indolocarbazole

June 13, 1997

Paracelsian cancels launch of AndroCar

June 12, 1997

Milkhaus initiates phase II trial for prostate cancer

June 11, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...